These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 19968782

  • 1. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M, Martell M, Raurell I, Ezkurdia N, Cuenca S, Hernández-Losa J, Esteban R, Guardia J, Bosch J, Genescà J.
    Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M, Genescà J, Raurell I, Rodríguez-Vilarrupla A, Mejías M, Otero T, Oria M, Esteban R, Guardia J, Bosch J, Martell M.
    J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
    [Abstract] [Full Text] [Related]

  • 3. Blockage of the afferent sensitive pathway prevents sympathetic atrophy and hemodynamic alterations in rat portal hypertension.
    Ezkurdia N, Coll M, Raurell I, Rodriguez S, Cuenca S, González A, Guardia J, Esteban R, Genescà J, Martell M.
    Liver Int; 2012 Sep; 32(8):1295-305. PubMed ID: 22292477
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R, Jurzik L, Moleda L, Froh M, Schnabl B, von Hörsten S, Schölmerich J, Straub RH.
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension.
    Resch M, Wiest R, Moleda L, Fredersdorf S, Stoelcker B, Schroeder JA, Schölmerich J, Endemann DH.
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G849-57. PubMed ID: 19696142
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L, Trebicka J, Dietrich P, Gäbele E, Hellerbrand C, Straub RH, Sauerbruch T, Schoelmerich J, Wiest R.
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [Abstract] [Full Text] [Related]

  • 11. Does local sympathetic atrophy contribute to splanchnic vasodilation in portal hypertension?
    Møller S, Stauber RE.
    Liver Int; 2010 Apr; 30(4):499-501. PubMed ID: 20158609
    [No Abstract] [Full Text] [Related]

  • 12. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
    Hartl J, Dietrich P, Moleda L, Müller-Schilling M, Wiest R.
    Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
    [Abstract] [Full Text] [Related]

  • 13. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
    Coll M, Rodriguez S, Raurell I, Ezkurdia N, Brull A, Augustin S, Guardia J, Esteban R, Martell M, Genescà J.
    Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
    Huang HC, Wang SS, Hsin IF, Chang CC, Lee FY, Lin HC, Chuang CL, Lee JY, Hsieh HG, Lee SD.
    Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
    [Abstract] [Full Text] [Related]

  • 16. Expression of cyclooxygenase in hyperdynamic portal hypertensive rats.
    Cao H, Xu J, Hua R, Meng FB, Qiu JF, Wu ZY.
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):252-6. PubMed ID: 16698586
    [Abstract] [Full Text] [Related]

  • 17. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
    Heinemann A, Wachter CH, Fickert P, Trauner M, Stauber RE.
    Hepatology; 1998 Sep; 28(3):646-54. PubMed ID: 9731553
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.